Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Severe chikungunya requiring intensive care in two travellers returning to the UK.

Calderwood C, Bhagani S, Cropley I, Papineni P.

J Travel Med. 2019 May 8. pii: taz033. doi: 10.1093/jtm/taz033. [Epub ahead of print] No abstract available.

PMID:
31066458
2.

Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies.

Iogna Prat L, Roccarina D, Lever R, Lombardi R, Rodger A, Hall A, Luong TV, Bhagani S, Tsochatzis EA.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):474-480. doi: 10.1097/QAI.0000000000001942.

PMID:
30807482
3.

Aetiology and severity of liver disease in HIV positive patients with suspected NAFLD: lessons from a cohort with available liver biopsies.

Iogna Prat L, Roccarina D, Lever R, Lombardi R, Rodger A, Hall A, Luong TV, Bhagani S, Tsochatzis E.

J Acquir Immune Defic Syndr. 2018 Dec 12. doi: 10.1097/QAI.0000000000001942. [Epub ahead of print]

PMID:
30570530
4.

HCV infection in HIV-negative MSM using HIV pre-exposure prophylaxis (PrEP)-Another piece of the jigsaw.

Bhagani S.

Liver Int. 2018 Oct;38(10):1733-1735. doi: 10.1111/liv.13937. No abstract available.

PMID:
30256512
5.

The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania.

Mohamed Z, Rwegasha J, Kim JU, Shimakawa Y, Poiteau L, Chevaliez S, Bhagani S, Taylor-Robinson SD, Thursz MR, Mbwambo J, Lemoine M.

J Viral Hepat. 2018 Dec;25(12):1438-1445. doi: 10.1111/jvh.12966. Epub 2018 Jul 30.

6.

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection.

Martinello M, Bhagani S, Gane E, Orkin C, Cooke G, Dore GJ, Petoumenos K, Applegate TL, Tu E, Marks P, Pagani N, Grebely J, Nelson M, Matthews GV.

J Viral Hepat. 2018 Oct;25(10):1180-1188. doi: 10.1111/jvh.12917. Epub 2018 May 8.

PMID:
29660224
7.

What do clinicians need to watch for with direct-acting antiviral therapy?

Aghemo A, Piroth L, Bhagani S.

J Int AIDS Soc. 2018 Apr;21 Suppl 2:e25076. doi: 10.1002/jia2.25076. Review.

8.

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.

Rockstroh JK, Lacombe K, Viani RM, Orkin C, Wyles D, Luetkemeyer AF, Soto-Malave R, Flisiak R, Bhagani S, Sherman KE, Shimonova T, Ruane P, Sasadeusz J, Slim J, Zhang Z, Samanta S, Ng TI, Gulati A, Kosloski MP, Shulman NS, Trinh R, Sulkowski M.

Clin Infect Dis. 2018 Sep 14;67(7):1010-1017. doi: 10.1093/cid/ciy220.

9.

Cure of chronic hepatitis C virus infection in an HIV-coinfected patient with multiple comorbidities and drug interaction challenges.

Álvarez H, Mariño A, Valcarce N, Khoo S, Bhagani S, Schapiro J, Llibre JM.

Int J STD AIDS. 2018 Aug;29(9):933-936. doi: 10.1177/0956462418755537. Epub 2018 Feb 21.

PMID:
29466917
10.

CD8+CD28-CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?

Fenoglio D, Dentone C, Signori A, Di Biagio A, Parodi A, Kalli F, Nasi G, Curto M, Cenderello G, De Leo P, Bartolacci V, Orofino G, Nicolini LA, Taramasso L, Fiorillo E, Orrù V, Traverso P, Bruzzone B, Ivaldi F, Mantia E, Guerra M, Negrini S, Giacomini M, Bhagani S, Filaci G.

J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov 2.

11.

European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.

De Wit S, Battegay M, D'Arminio Monforte A, Lundgren JD, Oprea C, Antinori A, Bhagani S, Fätkenheuer G, Friis-Moller N, Furrer H, Mussini C; European AIDS Clinical Society.

HIV Med. 2018 Feb;19(2):77-80. doi: 10.1111/hiv.12559. Epub 2017 Oct 27.

PMID:
29076235
12.

Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.

Mohamed Z, Mbwambo J, Shimakawa Y, Poiteau L, Chevaliez S, Pawlotsky JM, Rwegasha J, Bhagani S, Taylor-Robinson SD, Makani J, Thursz MR, Lemoine M.

J Int AIDS Soc. 2017 Sep 19;20(1):21856. doi: 10.7448/IAS.20.1.21856.

13.

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.

Rockstroh JK, Orkin C, Viani RM, Wyles D, Luetkemeyer AF, Lazzarin A, Soto-Malave R, Nelson MR, Bhagani SR, Klinker HHF, Rizzardini G, Girard PM, Tural C, Shulman NS, Mobashery N, Hu YB, Fredrick LM, Pilot-Matias T, Trinh R, Gane E.

Open Forum Infect Dis. 2017 Jul 22;4(3):ofx154. doi: 10.1093/ofid/ofx154. eCollection 2017 Summer.

14.

Hepatitis B, hepatitis C, and mortality among HIV-positive individuals.

Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C, Youssef E, Leen C, Gompels M, Kegg S, Schwenk A, Sabin C; UK Collaborative HIV cohort (UK CHIC) steering committee.

AIDS. 2017 Nov 28;31(18):2525-2532. doi: 10.1097/QAD.0000000000001646.

15.

Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers.

Lombardi R, Lever R, Smith C, Marshall N, Rodger A, Bhagani S, Tsochatzis E.

Ann Gastroenterol. 2017;30(3):349-356. doi: 10.20524/aog.2017.0141. Epub 2017 Apr 3.

16.

Highlights from the 24th Conference on Retroviruses and Opportunistic Infections: 13-16 February 2017, Seattle, Washington, USA.

Crowell TA, Lyall H, Malatinkova E, Bhagani S, Hsu D, Colby DJ, Polyak C, Psomas C, Hill A, Gathogo EN, Trypsteen W, Vandekerckhove L, Kinloch S.

J Virus Erad. 2017 Apr 1;3(2):101-108.

17.

Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.

Rockstroh JK, Bhagani S, Hyland RH, Yun C, Dvory-Sobol H, Zheng W, Brainard DM, Ingiliz P, Lutz T, Boesecke C, Nelson M.

Lancet Gastroenterol Hepatol. 2017 May;2(5):347-353. doi: 10.1016/S2468-1253(17)30003-1. Epub 2017 Mar 1.

PMID:
28397698
18.

Duodenal variceal bleed: an unusual cause of upper gastrointestinal bleed and a difficult diagnosis to make.

Bhagani S, Winters C, Moreea S.

BMJ Case Rep. 2017 Feb 27;2017. pii: bcr2016218669. doi: 10.1136/bcr-2016-218669.

19.

Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study.

Logan S, Rodger A, Maynard-Smith L, O'Beirne J, Fernandez T, Ferro F, Smith C, Bhagani S.

World J Hepatol. 2016 Dec 28;8(36):1623-1628. doi: 10.4254/wjh.v8.i36.1623.

20.

Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study.

Warren-Gash C, Childs K, Thornton A, Bhagani S, Demma S, Srivastava A, Leen C, Agarwal K, Rodger AJ, Sabin CA; Joint UK CHIC and liver transplant advisory group.

Infection. 2017 Apr;45(2):215-220. doi: 10.1007/s15010-016-0976-x. Epub 2017 Jan 4.

21.

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.

Ingiliz P, Martin TC, Rodger A, Stellbrink HJ, Mauss S, Boesecke C, Mandorfer M, Bottero J, Baumgarten A, Bhagani S, Lacombe K, Nelson M, Rockstroh JK; NEAT study group.

J Hepatol. 2017 Feb;66(2):282-287. doi: 10.1016/j.jhep.2016.09.004. Epub 2016 Sep 17.

PMID:
27650285
22.

Late Ebola virus relapse causing meningoencephalitis: a case report.

Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A, Gifford RJ, Hopkins S, Hughes J, Jabeen F, Johannessen I, Karageorgopoulos D, Lackenby A, Lester R, Liu RS, MacConnachie A, Mahungu T, Martin D, Marshall N, Mepham S, Orton R, Palmarini M, Patel M, Perry C, Peters SE, Porter D, Ritchie D, Ritchie ND, Seaton RA, Sreenu VB, Templeton K, Warren S, Wilkie GS, Zambon M, Gopal R, Thomson EC.

Lancet. 2016 Jul 30;388(10043):498-503. doi: 10.1016/S0140-6736(16)30386-5. Epub 2016 May 18.

23.

Ebola virus disease: the UK critical care perspective.

Martin D, Howard J, Agarwal B, Rajalingam Y, Athan B, Bhagani S, Cropley I, Hopkins S, Mepham S, Rodger A, Warren S, Jacobs M.

Br J Anaesth. 2016 May;116(5):590-6. doi: 10.1093/bja/aew098. Review.

24.

Neurosurgery and human immunodeficiency virus in the era of combination antiretroviral therapy: a review.

Henderson D, Sims-Williams HP, Wilhelm T, Sims-Williams H, Bhagani S, Thorne L.

J Neurosurg. 2017 Mar;126(3):897-907. doi: 10.3171/2016.1.JNS151194. Epub 2016 Apr 15.

PMID:
27081898
25.

United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015.

Brook G, Bhagani S, Kulasegaram R, Torkington A, Mutimer D, Hodges E, Hesketh L, Farnworth S, Sullivan V, Gore C, Devitt E, Sullivan AK; Clinical Effectiveness Group British Association for Sexual Health and HIV.

Int J STD AIDS. 2016 Jun;27(7):501-25. doi: 10.1177/0956462415624250. Epub 2016 Jan 7. No abstract available.

PMID:
26745988
26.

Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease.

Wilson AJ, Martin DS, Maddox V, Rattenbury S, Bland D, Bhagani S, Cropley I, Hopkins S, Mepham S, Rodger A, Warren S, Chowdary P, Jacobs M.

Clin Infect Dis. 2016 Mar 1;62(5):610-612. doi: 10.1093/cid/civ977. Epub 2015 Nov 26.

PMID:
26611775
27.

European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements.

Mussini C, Antinori A, Bhagani S, Branco T, Brostrom M, Dedes N, Bereczky T, Girardi E, Gökengin D, Horban A, Lacombe K, Lundgren JD, Mendao L, Mocroft A, Oprea C, Porter K, Podlekareva D, Battegay M, d'Arminio Monforte A; European Aids Clinical Society.

HIV Med. 2016 Jun;17(6):445-52. doi: 10.1111/hiv.12347. Epub 2015 Oct 22.

28.

Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.

Boesecke C, Ingiliz P, Reiberger T, Stellbrink HJ, Bhagani S, Page E, Mauss S, Lutz T, Voigt E, Guiguet M, Valantin MA, Baumgarten A, Nelson M, Vogel M, Rockstroh JK; NEAT Study Group.

Infection. 2016 Feb;44(1):93-101.

PMID:
26481253
29.

Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.

Gathogo E, Harber M, Bhagani S, Levy J, Jones R, Hilton R, Davies G, Post FA; UK HIV Kidney Transplantation Study Group.

Transplantation. 2016 Apr;100(4):871-8. doi: 10.1097/TP.0000000000000879.

PMID:
26413990
30.

Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy.

Calisti G, Muhindo R, Boum Y 2nd, Wilson LA, Foster GM, Geretti AM, Bhagani S.

Trans R Soc Trop Med Hyg. 2015 Nov;109(11):723-9. doi: 10.1093/trstmh/trv077. Epub 2015 Sep 18.

PMID:
26386408
31.

Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers.

Jacobs M, Aarons E, Bhagani S, Buchanan R, Cropley I, Hopkins S, Lester R, Martin D, Marshall N, Mepham S, Warren S, Rodger A.

Lancet Infect Dis. 2015 Nov;15(11):1300-4. doi: 10.1016/S1473-3099(15)00228-5. Epub 2015 Aug 25.

PMID:
26321189
32.

Ultra-deep sequencing provides insights into the virology of hepatitis C super-infections in a case of three sequential infections with different genotypes.

Chung E, Ferns RB, He M, Rigatti R, Grant P, McCormick A, Bhagani S, Webster DP, Nastouli E, Waters LJ.

J Clin Virol. 2015 Sep;70:63-66. doi: 10.1016/j.jcv.2015.06.105. Epub 2015 Jul 4. Review.

PMID:
26305822
33.

Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?

Karageorgopoulos DE, Allen J, Bhagani S.

World J Hepatol. 2015 Jul 28;7(15):1936-52. doi: 10.4254/wjh.v7.i15.1936. Review.

34.

Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.

Stockdale AJ, Phillips RO, Beloukas A, Appiah LT, Chadwick D, Bhagani S, Bonnett L, Sarfo FS, Dusheiko G, Geretti AM; Hepatitis B Infection in Kumasi (HEPIK) Study Group.

Clin Infect Dis. 2015 Sep 15;61(6):883-91. doi: 10.1093/cid/civ421. Epub 2015 May 28.

PMID:
26021992
35.

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.

Neukam K, Munteanu DI, Rivero-Juárez A, Lutz T, Fehr J, Mandorfer M, Bhagani S, López-Cortés LF, Haberl A, Stoeckle M, Márquez M, Scholten S, de Los Santos-Gil I, Mauss S, Rivero A, Collado A, Delgado M, Rockstroh JK, Pineda JA.

PLoS One. 2015 Apr 29;10(4):e0125080. doi: 10.1371/journal.pone.0125080. eCollection 2015.

36.

Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area.

Capocci S, Smith C, Morris S, Bhagani S, Cropley I, Abubakar I, Johnson M, Lipman M.

Eur Respir J. 2015 Jul;46(1):165-74. doi: 10.1183/09031936.00067114. Epub 2015 Apr 16.

37.

Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified.

Foster GR, Gore C, Hudson M, Moss P, Ustianowski A, Ryder S, Bhagani S.

BMJ. 2015 Feb 24;350:h998. doi: 10.1136/bmj.h998. No abstract available.

PMID:
25711900
38.

Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Matthews GV, Neuhaus J, Bhagani S, Mehta SH, Vlahakis E, Doroana M, Naggie S, Arenas-Pinto A, Peters L, Rockstroh JK; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:129-36. doi: 10.1111/hiv.12241.

39.

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

Dieterich D, Nelson M, Soriano V, Arastéh K, Guardiola JM, Rockstroh JK, Bhagani S, Laguno M, Tural C, Ingiliz P, Jain MK, Stern JO, Manero M, Vinisko R, Kort J; STARTVerso4 study group.

AIDS. 2015 Mar 13;29(5):571-81. doi: 10.1097/QAD.0000000000000579.

PMID:
25710287
40.

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries.

Hill A, Gotham D, Cooke G, Bhagani S, Andrieux-Meyer I, Cohn J, Fortunak J.

J Virus Erad. 2015 Apr 1;1(2):103-10.

41.

Diagnosis of polypoid portal hypertensive enteropathy due to superior mesenteric vein thrombosis by capsule endoscopy and double-balloon enteroscopy.

Laskaratos FM, Toumpanakis C, Clark I, Wylie P, Bhagani S, Despott EJ.

Endoscopy. 2014;46 Suppl 1 UCTN:E592-3. doi: 10.1055/s-0034-1390733. Epub 2014 Dec 11. No abstract available.

PMID:
25502255
42.

Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study.

Daskalopoulou M, Rodger A, Thornton A, Phillips A, Sherr L, Gilson R, Johnson M, Fisher M, Anderson J, McDonnell J, Edwards S, Perry N, Collins S, Bhagani S, Speakman A, Smith C, Lampe F.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19630. doi: 10.7448/IAS.17.4.19630. eCollection 2014.

43.

Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients.

McCormick AL, Moynihan L, Macartney MJ, Garcia-Diaz A, Smith C, Johnson MA, Rodger AJ, Bhagani S, Haque T, Webster DP.

Antivir Ther. 2015;20(3):361-3. doi: 10.3851/IMP2871. Epub 2014 Oct 3. No abstract available.

PMID:
25279548
44.

Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and United Kingdom.

Pujari SN, Smith C, Makane A, Youle M, Johnson M, Bele V, Joshi K, Dabhade D, Bhagani S.

BMC Infect Dis. 2014 Mar 29;14:173. doi: 10.1186/1471-2334-14-173.

45.

British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

Wilkins E, Nelson M, Agarwal K, Awoyemi D, Barnes E, Bhagani S, Brook G, Brown A, Castelino S, Cooke G, Fisher M, Geretti AM, James R, Kulasegaram R, Leen C, Mutimer D, Orkin C, Page E, Palfreeman A, Papineni P, Rodger A, Tong CY; British HIV Association.

HIV Med. 2013 Nov;14 Suppl 4:1-71. doi: 10.1111/hiv.12106. No abstract available.

46.

Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection.

Karageorgopoulos DE, El-Sherif O, Bhagani S, Khoo SH.

Curr Opin Infect Dis. 2014 Feb;27(1):36-45. doi: 10.1097/QCO.0000000000000034. Review.

PMID:
24305043
47.

Will antiretroviral therapy reduce HIV-related liver risk?

Allen J, Smith C, Bhagani S.

Curr Opin HIV AIDS. 2014 Jan;9(1):48-53. doi: 10.1097/COH.0000000000000022. Review.

PMID:
24247670
48.

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.

Rockstroh JK, Bhagani S.

BMC Med. 2013 Nov 1;11:234. doi: 10.1186/1741-7015-11-234. Review.

49.

Kidney transplantation in HIV-positive adults: the UK experience.

Gathogo EN, Hamzah L, Hilton R, Marshall N, Ashley C, Harber M, Levy JB, Jones R, Boffito M, Khoo SH, Drage M, Bhagani S, Post FA; UK HIV/Kidney Transplantation Study Group (see appendix).

Int J STD AIDS. 2014 Jan;25(1):57-66. doi: 10.1177/0956462413493266. Epub 2013 Jul 19.

PMID:
23970634
50.

'Occam's Scissors': opportunistic infections in advanced HIV infection.

Shah N, Owen L, Bhagani S.

BMJ Case Rep. 2013 Jul 5;2013. pii: bcr2013009544. doi: 10.1136/bcr-2013-009544.

Supplemental Content

Loading ...
Support Center